Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue

Stosic-Grujicic, S. (7004253020)S. (7004253020)Stosic-GrujicicMaksimovic-Ivanic, D. (6507584634)D. (6507584634)Maksimovic-IvanicMiljkovic, D. (7006524033)D. (7006524033)MiljkovicTrajkovic, V. (7004516866)V. (7004516866)TrajkovicLukic, M. (7005792112)M. (7005792112)LukicMostarica Stojkovic, M. (6701741422)M. (6701741422)Mostarica Stojkovic2025-06-132025-06-132002https://doi.org/10.1016/S0041-1345(02)03502-9https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036844325&doi=10.1016%2fS0041-1345%2802%2903502-9&partnerID=40&md5=d22507f9d074b42891e8f474c0528fb7https://remedy.med.bg.ac.rs/handle/123456789/11252[No abstract available]Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue